Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Our data offer a proof of concept for the treatment of SCD by MHC disparate non-myeloablative T cell-depleted HSCT, using anti-3rd party central memory veto CD8-positive T-cells.